Procedural Surgical RCTs in Daily Practice: Do Surgeons Adopt Or Is It Just a Waste of Time?


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
11 2019
Historique:
entrez: 22 10 2019
pubmed: 22 10 2019
medline: 17 3 2020
Statut: ppublish

Résumé

To assess the adoption of recommendation from randomized clinical trials (RCTs) and investigate factors favoring or preventing adoption. RCT are considered to be the cornerstone of evidence-based medicine by representing the highest level of evidence. As such, we expect RCT's recommendations to be followed rigorously in daily surgical practice. We performed a structured search for RCTs published in the medical and surgical literature from 2009 to 2013, allowing a minimum of 5-year follow-up to convincingly test implementation. We focused on comparative technical or procedural RCTs trials addressing the domains of general, colorectal, hepatobiliary, upper gastrointestinal and vascular surgery. In a second step we composed a survey of 29 questions among ESA members as well as collaborators from their institutions to investigate the adoption of surgical RCTs recommendation. The survey based on 36 RCTs (median 5-yr citation index 85 (24-474), from 21 different countries, published in 15 high-ranked journals with a median impact factor of 3.3 (1.23-7.9) at the time of publication. Overall, less than half of the respondents (47%) appeared to adhere to the recommendations of a specific RCT within their field of expertise, even when included in formal guidelines. Adoption of a new surgical practice was favored by watching videos (46%) as well as assisting live operations (18%), while skepticism regarding the methodology of a surgical RCT (40%) appears to be the major reason to resist adoption. In conclusion, surgical RCTs appear to have moderate impact on daily surgical practice. While RCTs are still accepted to provide the highest level of evidence, alternative methods of evaluating surgical innovations should also be explored.

Sections du résumé

OBJECTIVE
To assess the adoption of recommendation from randomized clinical trials (RCTs) and investigate factors favoring or preventing adoption.
BACKGROUND
RCT are considered to be the cornerstone of evidence-based medicine by representing the highest level of evidence. As such, we expect RCT's recommendations to be followed rigorously in daily surgical practice.
METHODS
We performed a structured search for RCTs published in the medical and surgical literature from 2009 to 2013, allowing a minimum of 5-year follow-up to convincingly test implementation. We focused on comparative technical or procedural RCTs trials addressing the domains of general, colorectal, hepatobiliary, upper gastrointestinal and vascular surgery. In a second step we composed a survey of 29 questions among ESA members as well as collaborators from their institutions to investigate the adoption of surgical RCTs recommendation.
RESULTS
The survey based on 36 RCTs (median 5-yr citation index 85 (24-474), from 21 different countries, published in 15 high-ranked journals with a median impact factor of 3.3 (1.23-7.9) at the time of publication. Overall, less than half of the respondents (47%) appeared to adhere to the recommendations of a specific RCT within their field of expertise, even when included in formal guidelines. Adoption of a new surgical practice was favored by watching videos (46%) as well as assisting live operations (18%), while skepticism regarding the methodology of a surgical RCT (40%) appears to be the major reason to resist adoption.
CONCLUSION
In conclusion, surgical RCTs appear to have moderate impact on daily surgical practice. While RCTs are still accepted to provide the highest level of evidence, alternative methods of evaluating surgical innovations should also be explored.

Identifiants

pubmed: 31634176
doi: 10.1097/SLA.0000000000003546
pii: 00000658-201911000-00002
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

727-734

Auteurs

Christian E Oberkofler (CE)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Jacob F Hamming (JF)

Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Roxane D Staiger (RD)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Philippe Brosi (P)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Sebastiano Biondo (S)

Department of General and Digestive Surgery, Bellvitge University Hospital, Barcelona, Spain.

Olivier Farges (O)

Department of Surgery and Transplantation, Hôpital Beaujon, Clichy, France.

Dink A Legemate (DA)

Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Mario Morino (M)

Department of Digestive Surgery, Hospital San Giovanni Battista, University of Torino, Torino, Italy.

Antonio D Pinna (AD)

Digestive Disease Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates.

Hugo Pinto-Marques (H)

Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal.

John V Reynolds (JV)

Department of General Surgery, St. James's Hospital, Dublin, Ireland.

Ricardo Robles Campos (RR)

Department of Surgery and Transplantation, Virgen de la Arrixaca Clinic and University Hospital, Murcia, Spain.

Xavier Rogiers (X)

Department of Surgery and Transplantation, Gent University Hospital and Medical School UZG, Gent, Belgium.

Kjetil Soreide (K)

Department of Clinical Medicine, Gastrointestinal Surgery, HPB unit, Stavanger, Norway.

Milo A Puhan (MA)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Pierre-Alain Clavien (PA)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Inne Borel Rinkes (IB)

Department Surgical Oncology, Endocrine and GI Surgery, University Hospital Utrecht, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH